Key Features

Fmoc Protection：Optimized for solid-phase peptide synthesis (SPPS), enabling efficient coupling in GLP-1 analog development.

Aib Residue：Introduces backbone rigidity, enhancing bolic stability in long-acting peptides.

Low Impurity Profile：Single impurity ≤0.5%, total impurities ≤1.0% (COA available upon request).

Applications

Semaglutide & GLP-1 Agonist Synthesis：Critical for constructing the His-Aib motif in Semaglutide's amino acid sequence, improving synthetic efficiency by 20%+ compared to standard derivatives.

Peptide Drug Discovery：Suitable for library screening in obesity, diabetes, and bolic disease research.

cGMP-Compliant Production：Scalable from 100 mg to 5 kg batches, supporting preclinical research to commercial manufacturing.

Regulatory Compliance

ISO 9001:2015 & ISO 14001 Certified：Manufactured in a cGMP-compliant facility with strict quality control.

Global Regulatory Support：Provides DMF, CE, and REACH registration documents for EU/US markets.

Stability Testing：Validated for 24 months under -20°C dry storage.

Analytical Data

1446013-08-6 HNMR

1446013-08-6 LCMS

Services Offered

Custom Modifications：Alternative protection groups (e.g., Boc, Cbz) or isotopic labeling upon request.

Rush Services：24-hour turnaround for urgent orders (subject to availability).

Technical Consultation：Free peptide synthesis optimization by our PhD-level chemists.

Company Profile

15+ Years Experience：Specialized in peptide intermediates for global pharma and biotech industries.

R&D Capability：30+ scientists in a 2,000㎡ state-of-the-art laboratory.

Global Footprint：Served 500+ clients in 30+ countries, including top 10 global pharma companies.

Contact Us

Email：export@pu-kang.com

Phone：+86-137-0808-4407

Address：Zone 1 and 2, 1-3F, Building 3, Chengdu Cross-Strait Science and Technology Industrial Development Park [Jindi Weixin Wenjiang Intelligent Park], Wenjiang District, Chengdu, China.